Sumitomo Pharma Co., Ltd. (TYO:4506)
Japan · Delayed Price · Currency is JPY 1,514.50
+77.50 (5.39%)
Jun 8, 2026, 3:30 PM JST
Sumitomo Pharma Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Sumitomo Pharma stock has a consensus rating of "Hold" and an average price target of ¥2,074. The average 1-year stock price forecast is 36.91% higher than the current stock price, while the lowest is ¥1,415 (-6.57%) and the highest is ¥2,700 (+78.28%).
Price Target: ¥2,074 (+36.91%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Sumitomo Pharma stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 2 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 7 | 7 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Sell Maintains ¥1,500 | Sell | Maintains | ¥1,500 | -0.96% | May 26, 2026 |
| Jefferies | Jefferies | Buy Maintains ¥2,700 | Buy | Maintains | ¥2,700 | +78.28% | Dec 16, 2025 |
Financial Forecast
Revenue This Year
544.98B
from 453.29B
Increased by 20.23%
Revenue Next Year
581.00B
from 544.98B
Increased by 6.61%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 566.3B | ||
| Avg | 545.0B | ||
| Low | 530.2B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 24.9% | ||
| Avg | 20.2% | ||
| Low | 17.0% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
EPS Growth
| EPS Growth | 2028 | 2029 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |